1. Home
  2. ERII vs CGEM Comparison

ERII vs CGEM Comparison

Compare ERII & CGEM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Energy Recovery Inc.

ERII

Energy Recovery Inc.

HOLD

Current Price

$14.22

Market Cap

740.3M

Sector

Technology

ML Signal

HOLD

Logo Cullinan Oncology Inc.

CGEM

Cullinan Oncology Inc.

HOLD

Current Price

$10.87

Market Cap

671.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ERII
CGEM
Founded
1992
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
740.3M
671.7M
IPO Year
2008
2021

Fundamental Metrics

Financial Performance
Metric
ERII
CGEM
Price
$14.22
$10.87
Analyst Decision
Buy
Strong Buy
Analyst Count
2
8
Target Price
$16.50
$28.13
AVG Volume (30 Days)
406.0K
934.6K
Earning Date
02-25-2026
02-26-2026
Dividend Yield
N/A
N/A
EPS Growth
7.56
N/A
EPS
0.36
N/A
Revenue
$135,191,000.00
N/A
Revenue This Year
$5.93
N/A
Revenue Next Year
$8.97
N/A
P/E Ratio
$40.32
N/A
Revenue Growth
0.10
N/A
52 Week Low
$10.86
$5.68
52 Week High
$18.32
$13.33

Technical Indicators

Market Signals
Indicator
ERII
CGEM
Relative Strength Index (RSI) 49.56 55.27
Support Level $14.10 $10.04
Resistance Level $14.55 $11.60
Average True Range (ATR) 0.35 0.66
MACD 0.07 0.03
Stochastic Oscillator 71.26 68.72

Price Performance

Historical Comparison
ERII
CGEM

About ERII Energy Recovery Inc.

Energy Recovery Inc is an engineering-driven technology company. It is engaged in engineering, designing, manufacturing and supplying solutions that make industrial processes more efficient and sustainable. The company operates in three segments, Water, Emerging Technologies and Corporate. It offers energy recovery devices (ERDs) and pumps as well as related products and services to the reverse osmosis desalination market. The company derives a majority of the revenue from the Water segment. Geographically, the company operates in the U.S. and other international countries.

About CGEM Cullinan Oncology Inc.

Cullinan Therapeutics Inc is a biopharmaceutical company. It has a diversified portfolio of clinical-stage assets that inhibit key drivers of disease or harness the immune system to eliminate diseased cells in both oncology and autoimmune diseases. Its understanding of oncology, immunology, and translational medicine, creates differentiated ideas, identifies the appropriate targets, and selects the optimal modality to develop transformative therapeutics across a variety of cancer and autoimmune indications. It has one reporting and one operating segment, which is the business of developing immunology and oncology therapies.

Share on Social Networks: